Skip to main content

$0.001 (0%)

High

$0.00

Low

$0.00

Trades

6

Turnover

$4,631

Volume

4,631,202
30 June 2023 at 3:48pm
Register to track MEB and receive email alerts.
Subject
MEB Ann: Letter to Optionholders - Entitlement Offer

MEB Ann: Update - Proposed issue of securities - MEB

MEB Ann: Entitlement Offer Document

MEB Ann: Section 708AA(2)(F) Cleansing Notice - Entitlement Offer

MEB Ann: Non-Renounceable Entitlement Offer Underwriting Update

MEB Ann: Notification regarding unquoted securities - MEB

MEB Ann: Update - Proposed issue of securities - MEB

MEB Ann: Notification of cessation of securities - MEB

MEB Ann: Update to Entitlement Offer Timetable

MEB Ann: Notice of Extraordinary General Meeting/Proxy Form

MEB Ann: Section 708A Cleansing Notice

MEB Ann: Application for quotation of securities - MEB

MEB Ann: Section 708A Cleansing Notice

MEB Ann: Investor Presentation December 2021

MEB Ann: Proposed issue of securities - MEB

MEB Ann: Proposed issue of securities - MEB

MEB Ann: MEB to Raise up to $5.7 million by way of a Placement & NREO

MEB Ann: Trading Halt

MEB Ann: Appendix 3Y

MEB Ann: Application for quotation of securities - MEB

MEB Ann: Results of Annual General Meeting

MEB Ann: Chairman's Address to the 2021 Annual General Meeting

MEB Ann: JobKeeper Payments Notice

MEB Ann: Medibio Quarterly Update and Cashflow Report

MEB Ann: Expiry of MEBOB Quoted Options

MEB Ann: FDA Strategy and Regulatory Update

MEB Ann: Proposed issue of securities - MEB

MEB Ann: Notice of Annual General Meeting/Proxy Form

MEB Ann: LUCA Launches Today

MEB Ann: Appointment of Dr Elizabeth Lambardo to Advisory Board

MEB Ann: CEO/MD Remuneration Update and Company Secretary Resignation

MEB Ann: Appendix 4G and Corporate Governance Statement

MEB Ann: Appendix 4E and Annual Report

MEB Ann: Medibio Quarterly Update and Cashflow Report

MEB Ann: Newsletter to Shareholders

MEB Ann: MEB Appoints R&CPMK As Communications Agency in the US

MEB Ann: Section 708A Cleansing Notice and Appendix 2A

MEB Ann: Medibio strengthens its IP protection

MEB Ann: Medibio Quarterly Update and Cashflow Report

MEB Ann: Re-submission of FDA 510(k) application

MEB Ann: Consumer Mental Health App Development - Second Test Phase

MEB Ann: Appendix 3G

MEB Ann: Appendix 2A

MEB Ann: Appendix 2A

MEB Ann: Appendix 2A

MEB Ann: Appendix 2A

MEB Ann: Section 708A Cleansing Notice and Appendix 2A

MEB Ann: Appendix 2A

MEB Ann: Proposed issue of Securities - MEB (Revised)

MEB Ann: MEB Share Purchase Plan Closes Strongly Oversubscribed

Register to track MEB and receive email alerts.

Similar Companies

4DX
ALC
CGS
IME
M7T
MDR
PCK
PKS
PME
RAP